Stay updated with breaking news from Sci Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JENA, Germany, April 14, 2023 -- InflaRx N.V. , a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today that it has... | April 14, 2023
DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc ("Avadel") (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today
DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (“Avadel”) (Nasdaq: AVDL), a biopharmaceutical company focused on...
Trailblazer Merger I Corp. (TBMCU) expects to raise $60 million in an initial public offering (IPO) on Wednesday, March 29th, IPO Scoop reports. The company will issue 6,000,000 shares at $10.00 per share. The company has a market-cap of $78.6 million. LifeSci Capital and Ladenburg Thalmann acted as the underwriters for the IPO. Trailblazer Merger […]
BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused on...